<i>ADAM12</i> as a Clinical Prognostic Indicator Associated with Tumor Immune Infiltration in Lung Adenocarcinoma.

Pan, Junfan; Huang, Zhidong; Zhang, Yuan; Xu, Yiquan

ADAM12 as a Clinical Prognostic Indicator Associated with Tumor Immune Infiltration in Lung Adenocarcinoma.

Pan, Junfan; Huang, Zhidong; Zhang, Yuan; Xu, Yiquan.

Afiliação

Pan J; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Huang Z; Quanzhou First Hospital of Fujian Medical University, Quanzhou, China.
Zhang Y; The First Affiliated Hospital of Xiamen University, Xiamen, China.
Xu Y; Department of Thoracic Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China.

DNA Cell Biol ; 41(4): 410-423, 2022 Apr.

Article em En | MEDLINE | ID: mdl-35377217

Assuntos

Proteína ADAM12; Adenocarcinoma de Pulmão; Neoplasias Pulmonares; Proteína ADAM12/genética; Adenocarcinoma de Pulmão/patologia; Biomarcadores Tumorais/genética; Humanos; Neoplasias Pulmonares/patologia; Prognóstico; Microambiente Tumoral/genética

Palavras-chave

ADAM12; lung adenocarcinoma; prognostic indicator; tumor immune microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína ADAM12 / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google